Healthcare information provider Wolters Kluwer Health (WK Health), US, has entered into an expanded distribution agreement with the New England Journal of Medicine (NEJM). Under the deal, Ovid, part of Wolters Kluwer Health, will be the only medical research aggregator to distribute current, non-embargoed NEJM content to institutions and their clinicians, researchers and students who need fast access to the latest medical and clinical literature. The OvidSP medical research platform is used by more than 12,500 institutions worldwide.
Ovid customers will have site-wide access to current issues of the New England Journal of Medicine through 1990 in PDF format, plus links to Online First articles. Ovid had previously offered NEJM content through 1993, as HTML only.
Ovid is a global information solutions provider offering clinicians, researchers, and students in the medical, scientific, and academic fields customisable solutions of content, tools, and services that make research smarter, faster, and more effective. Its flagship search platform, OvidSP is a robust search platform used by the world’s leading medical and academic institutions as well as pharmaceutical companies, among other companies. The system averages more than 1.3 billion page views annually, with about 620 full text downloads occurring ever minute, globally.
Founded in 1812, and owned by the Massachusetts Medical Society, the New England Journal of Medicine (NEJM.org) publishes peer-reviewed research and interactive clinical content for physicians, educators and the global medical community.
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
